AstraZeneca Personalized Medicine Team has 10 Projects In The Clinic - McHale
This article was originally published in The Pink Sheet Daily
Duncan McHale joined the firm in May as personalized health care medical director.
You may also be interested in...
Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested
Former senior advisor to President Trump warns that failure to reform drug pricing practices has seriously handicapped prospects for reimbursing cell and gene therapy under existing US payer programs.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’